Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 583.51-91.805.4623.93404.51

What is the latest EBIT Growth ratio of BALAXI PHARMACEUTICALS ?

The latest EBIT Growth ratio of BALAXI PHARMACEUTICALS is 583.51 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025583.51
Mar2024-91.80
Mar20235.46
Mar202223.93
Mar2021404.51

How is EBIT Growth of BALAXI PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 583.51
Positive
Mar2024 -91.8
Negative
Mar2023 5.46
-77.18
Mar2022 23.93
-94.08
Mar2021 404.51 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare EBIT Growth ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹132.0 Cr 27.2% 31.7% -65.8% Stock Analytics
ADANI ENTERPRISES ₹264,166.0 Cr 10.9% -2.2% -16.9% Stock Analytics
REDINGTON ₹17,066.1 Cr 7.7% -12.3% -10% Stock Analytics
HONASA CONSUMER ₹10,177.6 Cr 1.8% 4.9% 29.2% Stock Analytics
LLOYDS ENTERPRISES ₹8,999.0 Cr 31.6% 20.2% 22.1% Stock Analytics
MMTC ₹8,805.0 Cr 6.3% 3.2% 5.2% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

27.2%

31.7%

-65.8%

SENSEX

7.8%

-2%

0.2%


You may also like the below Video Courses